tiprankstipranks
Trending News
More News >

Jane Wasman Insider Profile

4 Followers
Jane Wasman, President, Intl and GC at Acorda Therapeutics, holds 30.40K shares in SELLAS Life Sciences Group (Ticker: SLS), holds 12.50K shares in Rigel (Ticker: RIGL), holds 35.14K shares in Athersys (Ticker: ATHXQ). Most recently, Jane Wasman Bought ― shares of SELLAS Life Sciences Group on Jun 02, 2025 for an estimated value of 33.80K.
tipranks
Jane Wasman

Jane Wasman
Acorda Therapeutics (ACORQ)
President, Intl and GC

Ranked #71,630 out of 102,830 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-16.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$421K
88.52%
11.48%
0.00%
A breakdown of Jane Wasman's holdings

Insider Roles

Rigel
(RIGL)
Director
SELLAS Life Sciences Group
(SLS)
Director
Athersys
(ATHXQ)
Director
Roles that Jane Wasman holds in companies

Most Profitable Insider Trade

Stock:
SELLAS Life Sciences Group
(SLS)
Rating:Informative Buy
Date:Jun 02, 2025 - Today
Return:+5.00%
The most profitable trade made by Jane Wasman

Jane Wasman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACORQ
Acorda Therapeutics
Dec 04, 2019
Uninformative Sell
3.54K
$1.53K
SELLAS Life Sciences Group
Jun 02, 2025
Director
Informative Buy
33.80K
$48.34K
Rigel
May 28, 2025
Director
Uninformative Buy
$372.63K
Athersys
Jan 11, 2023
Director
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Jane Wasman's performance on stock

Jane Wasman insider profile FAQ

What is the percentage of profitable transactions made by Jane Wasman?
The percentage of profitable transactions made by Jane Wasman is 33%.
    What is the average return per transaction made by Jane Wasman?
    The average return per transaction made by Jane Wasman is -16.70%.
      What stocks does Jane Wasman hold?
      Jane Wasman holds: ACORQ, SLS, RIGL, ATHXQ stocks.
        What was Jane Wasman’s latest transaction?
        Jane Wasman latest transaction was an Informative Buy of $33.80K.
          What was Jane Wasman's most profitable transaction?
          Jane Wasman’s most profitable transaction was an Informative Buy of SLS stock on June 2, 2025. The return on the trade was 5.00%.
            What is Jane Wasman's role in Acorda Therapeutics?
            Jane Wasman's role in Acorda Therapeutics is President, Intl and GC.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.